These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30300947)

  • 1. Potentially Inappropriate Medications in Older Adults: Deprescribing with a Clinical Pharmacist.
    Ammerman CA; Simpkins BA; Warman N; Downs TN
    J Am Geriatr Soc; 2019 Jan; 67(1):115-118. PubMed ID: 30300947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care.
    McDonald EG; Wu PE; Rashidi B; Forster AJ; Huang A; Pilote L; Papillon-Ferland L; Bonnici A; Tamblyn R; Whitty R; Porter S; Battu K; Downar J; Lee TC
    J Am Geriatr Soc; 2019 Sep; 67(9):1843-1850. PubMed ID: 31250427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.
    Jovevski JJ; Smith CR; Roberts JL; Dev S; Iloabuchi TC; Gruber EA; Williams MJ; Slaven JE; Mitchell AM
    Acad Emerg Med; 2023 Apr; 30(4):410-419. PubMed ID: 36794336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
    Komagamine J; Sugawara K; Hagane K
    BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
    Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
    Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deprescribing in Primary Care in Singapore: Barriers and Facilitators.
    Chia HS; Bek ESJ
    Consult Pharm; 2018 Nov; 33(11):637-648. PubMed ID: 30458906
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of the Tool to Reduce Inappropriate Medications on Medication Communication and Deprescribing.
    Fried TR; Niehoff KM; Street RL; Charpentier PA; Rajeevan N; Miller PL; Goldstein MK; O'Leary JR; Fenton BT
    J Am Geriatr Soc; 2017 Oct; 65(10):2265-2271. PubMed ID: 28804870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Academic Detailing with Provider Audit and Feedback Improve Prescribing Quality for Older Veterans.
    Vandenberg AE; Echt KV; Kemp L; McGwin G; Perkins MM; Mirk AK
    J Am Geriatr Soc; 2018 Mar; 66(3):621-627. PubMed ID: 29532466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balancing medication use in nursing home residents with life-limiting disease.
    Paque K; Elseviers M; Vander Stichele R; Pardon K; Vinkeroye C; Deliens L; Christiaens T; Dilles T
    Eur J Clin Pharmacol; 2019 Jul; 75(7):969-977. PubMed ID: 30834473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist-led medication review in a residential in-reach service leads to deprescribing.
    Hui JH; Parikh S; Kouladjian O'Donnell L; Mcinerney B; Dillon L; Poojary S; Crabtree A
    Australas J Ageing; 2023 Dec; 42(4):675-682. PubMed ID: 37198738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.
    Thillainadesan J; Gnjidic D; Green S; Hilmer SN
    Drugs Aging; 2018 Apr; 35(4):303-319. PubMed ID: 29541966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs prescribed for patients hospitalized in a geriatric oncology unit: Potentially inappropriate medications and impact of a clinical pharmacist.
    Deliens C; Deliens G; Filleul O; Pepersack T; Awada A; Piccart M; Praet JP; Lago LD
    J Geriatr Oncol; 2016 Nov; 7(6):463-470. PubMed ID: 27238734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Pharmacy Medication Reviews on the Prescribing of Potentially Inappropriate Medications for Older Veterans in Primary Care.
    Chen J; Sena K; Nawarskas AD; Smith CA; Ward K
    Sr Care Pharm; 2019 Jul; 34(7):464-472. PubMed ID: 31383058
    [No Abstract]   [Full Text] [Related]  

  • 15. A pharmacist-led pilot program to facilitate deprescribing in a primary care clinic.
    Clark CM; LaValley SA; Singh R; Mustafa E; Monte SV; Wahler RG
    J Am Pharm Assoc (2003); 2020; 60(1):105-111. PubMed ID: 31690514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Impact of Medication Safety Alerts on Prescribing of Potentially Inappropriate Medications for Older Veterans in an Ambulatory Care Setting.
    Vanderman AJ; Moss JM; Bryan WE; Sloane R; Jackson GL; Hastings SN
    J Pharm Pract; 2017 Feb; 30(1):82-88. PubMed ID: 26702027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT).
    Van der Linden L; Hias J; Dreessen L; Milisen K; Flamaing J; Spriet I; Tournoy J
    BMC Geriatr; 2018 Jul; 18(1):155. PubMed ID: 29970005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Clinical Pharmacy Specialists on the Design and Implementation of a Quality Improvement Initiative to Decrease Inappropriate Medications in a Veterans Affairs Emergency Department.
    Moss JM; Bryan WE; Wilkerson LM; Jackson GL; Owenby RK; Van Houtven C; Stevens MB; Powers JS; Vaughan CP; Hung WW; Hwang U; Markland AD; McGwin G; Hastings SN
    J Manag Care Spec Pharm; 2016 Jan; 22(1):74-80. PubMed ID: 27015054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DE-PHARM Project: A Pharmacist-Driven Deprescribing Initiative in a Nursing Facility.
    Pruskowski J; Handler SM
    Consult Pharm; 2017 Aug; 32(8):468-478. PubMed ID: 29029668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of potentially inappropriate medication use in residential aged care facilities.
    Harrison SL; Kouladjian O'Donnell L; Milte R; Dyer SM; Gnanamanickam ES; Bradley C; Liu E; Hilmer SN; Crotty M
    BMC Geriatr; 2018 Jan; 18(1):9. PubMed ID: 29325531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.